Later, the co-occurrence with other neurological and autoimmune diseases, most notably type 1 diabetes mellitus (T1DM), led to the discovery of the association with antibodies against glutamic acid decarboxylase (GAD) [3]. This evidence concerns the gene GAD1 and type 1 diabetes mellitus.